|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1999-3-22
|
|
pubmed:abstractText |
We analyzed 92 Cryptosporidium parvum isolates from humans and animals by a polymerase chain reaction/restriction fragment length polymorphism method based on the thrombospondin-related anonymous protein 2 gene sequence. Used as a molecular marker, this method can differentiate between the two genotypes of C. parvum and elucidate the transmission of infection to humans.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1080-6040
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
681-5
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:9866750-Animals,
pubmed-meshheading:9866750-Cattle,
pubmed-meshheading:9866750-Cattle Diseases,
pubmed-meshheading:9866750-Cryptosporidiosis,
pubmed-meshheading:9866750-Cryptosporidium parvum,
pubmed-meshheading:9866750-Disease Outbreaks,
pubmed-meshheading:9866750-Genotype,
pubmed-meshheading:9866750-Humans,
pubmed-meshheading:9866750-Polymerase Chain Reaction,
pubmed-meshheading:9866750-Polymorphism, Restriction Fragment Length,
pubmed-meshheading:9866750-Protozoan Proteins,
pubmed-meshheading:9866750-Sequence Analysis, DNA
|
|
pubmed:articleTitle |
Differentiating human from animal isolates of Cryptosporidium parvum.
|
|
pubmed:affiliation |
Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.
|
